These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22566701)

  • 1. Stroke and renal dysfunction: are we always conscious of this relationship?
    Fabbian F; Casetta I; De Giorgi A; Pala M; Tiseo R; Portaluppi F; Manfredini R
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):305-11. PubMed ID: 22566701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A risk factors for stroke in the patients with chronic kidney disease].
    Kes P; Basić-Kes V; Basić-Jukić N; Jurić I
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():67-77. PubMed ID: 23120820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke and renal dysfunction.
    Hojs Fabjan T; Hojs R
    Eur J Intern Med; 2014 Jan; 25(1):18-24. PubMed ID: 24070520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure.
    Baber U; Toto RD; de Lemos JA
    Am Heart J; 2007 Apr; 153(4):471-7. PubMed ID: 17383281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reno-cerebrovascular disease: linking the nephron and neuron.
    Lee M; Ovbiagele B
    Expert Rev Neurother; 2011 Feb; 11(2):241-9. PubMed ID: 21306211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
    Varma R; Garrick R; McClung J; Frishman WH
    Cardiol Rev; 2005; 13(2):98-107. PubMed ID: 15705261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke.
    Ovbiagele B
    Arch Neurol; 2008 Jul; 65(7):934-8. PubMed ID: 18625861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.
    Rodriguez-Iturbe B; Correa-Rotter R
    Expert Opin Pharmacother; 2010 Nov; 11(16):2687-98. PubMed ID: 20426701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T; Nishizawa Y
    Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease.
    Tripepi G; Mattace-Raso F; Rapisarda F; Stancanelli B; Malatino L; Witteman J; Zoccali C; Mallamaci F
    J Hypertens; 2010 Dec; 28(12):2468-74. PubMed ID: 20724936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the treatment and management of stroke.
    Ledger S
    CANNT J; 2006; 16(1):30-3, 36-9; quiz 34-5, 40-1. PubMed ID: 16615704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.